Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Shielding evaluation for IMRT implementation in an existing accelerator vault.

R A Price1, O Chibani, C-M Ma

  • 1Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania 19111, USA. r_price@fccc.edu

Journal of Applied Clinical Medical Physics
|July 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow.

Brachytherapy·2024
Same author

An in-vivo study of the combined therapeutic effects of pulsed non-thermal focused ultrasound and radiation for prostate cancer.

International journal of radiation biology·2023
Same author

A narrative review of pyrolysis and its role in ulcerative colitis.

European review for medical and pharmacological sciences·2022
Same author

Application of a directional palladium-103 brachytherapy device on a curved surface.

Medical physics·2019
Same author

Simian Neonatology: I. Gestational Maturity and Extrauterine Viability.

Veterinary pathology·2018
Same author

SU-E-T-464: Impact of the Treatment Margin on Tumor Control and Normal Tissue Complication for Prostate Treatment.

Medical physics·2017
Same journal

Synthetic CT-enabled weekly adaptive radiotherapy for nasopharyngeal carcinoma: Optimizing plan adaptation triggers through volumetric-dosimetric monitoring.

Journal of applied clinical medical physics·2026
Same journal

Method for simultaneous selection of treatment isocenters and margins for polymetastatic extracranial stereotactic ablative radiotherapy.

Journal of applied clinical medical physics·2026
Same journal

Pulse‑level characterization of low monitor unit deliveries on a modern linear accelerator using a plastic scintillation detector.

Journal of applied clinical medical physics·2026
Same journal

Improving image quality in terbium-161 phantom imaging: Quantitative evaluation of DEW and TEW scatter correction methods.

Journal of applied clinical medical physics·2026
Same journal

Latent density discrepancies in commercial lung-equivalent inserts and their clinical dosimetric impact.

Journal of applied clinical medical physics·2026
Same journal

Explainable machine learning for patient-specific quality assurance in intensity-modulated radiotherapy based on anatomical structures.

Journal of applied clinical medical physics·2026
See all related articles

Shielding for Intensity-Modulated Radiation Therapy (IMRT) vaults is evaluated using exposure measurements and a new modulation scaling factor. An 18 MV Siemens linear accelerator shows significantly lower neutron production, reducing secondary cancer risk.

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Radiological Shielding

Background:

  • Vault shielding is critical for radiation protection in medical facilities.
  • Intensity-Modulated Radiation Therapy (IMRT) requires careful assessment of radiation shielding.
  • Neutron production from high-energy linear accelerators poses a risk for secondary malignancies.

Purpose of the Study:

  • To develop a formalism for evaluating shielding in existing vaults for IMRT.
  • To assess neutron production and patient risks associated with 18 MV IMRT delivery.
  • To compare neutron output and associated risks between different linear accelerator models.

Main Methods:

  • Utilized existing exposure rate measurements.
  • Developed and applied an effective modulation scaling factor.

Related Experiment Videos

  • Employed Monte Carlo simulations to estimate neutron production differences.

    • Main Results:

    • The study provides examples for vaults with 6, 10, and 18 MV linear accelerators.
    • An 18 MV Siemens linear accelerator demonstrated approximately 4 times less neutron production than a Varian accelerator.
    • The estimated risk of fatal secondary malignancy was approximately 1.6% for SMLC delivery on the Siemens accelerator.

    Conclusions:

    • The developed formalism effectively evaluates vault shielding for IMRT.
    • The Siemens 18 MV accelerator presents a lower neutron production risk compared to the Varian accelerator.
    • The risk of secondary malignancies is comparable to previous findings for 3D CRT delivery.